资讯

After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter ...
Novavax can finally breathe a sigh of relief – at least a small one. The Food and Drug Administration approved the company's ...
The notice came shortly after an advisory panel meeting at which members debated the pros and cons of asking manufacturers to ...
The FDA has approved the Novavax COVID-19 vaccine, called Nuvaxovid, mainly for adults 65 or older, but people ages 12 to 64 with medical conditions that increase their risk of serious illness from ...
Previously granted Emergency Use Authorization, Nuvaxovid is now available for individuals over 12 years of age.
The agency narrowed who can get the shot and added new study requirements that could cost the company tens of millions.
The Food and Drug Administration says it has decided to continue approving COVID-19 vaccine updates for seniors and others at ...
Italian tyre maker Pirelli is in a risky situation after its Chinese leading shareholder Sinochem rejected a proposal by the ...
Covid shots are facing greater scrutiny from top federal health officials like RFK Jr. and the FDA's Marty Makary.
The FDA has approved Novavax’s protein-based COVID-19 vaccine, giving some Americans another option besides messenger RNA ...
WASHINGTON — The Food and Drug Administration has issued a long-awaited approval of Novavax’s COVID-19 vaccine but with ...
The Novavax Covid-19 vaccine, which uses more traditional protein-based technology than the mRNA vaccines from Pfizer/BioNTech and Moderna, has been subject to emergency use authorization since 2022.